Media Coverage

Cell-Based Assays Keep Biosimilars on Track

  • Published on: January 1, 2017

The cell-based assay has become a mainstay of drug development, addressing new concerns raised by the advent of biologics. Whereas small molecule drugs may escape…

Read More

How Durham’s BioAgilytix courted a German bioanalytical lab

  • Published on: February 22, 2016

See the Triangle Business Journal’s feature on BioAgilytix’s acquisition of IPM Biotech.

Read More

Building Partnerships with Other CROs

  • Published on: December 15, 2015

By nature, the idea of CRO partnerships is attractive to Executives and Business Development Teams because such alignments equip their CRO with a more comprehensive,…

Read More

How to Win Client Trust as a CRO

  • Published on: September 23, 2015

The act of building trust with your pharmaceutical and biotech clients is similar to how trust is built between friends – both require time, mutual…

Read More

How to Set up a Successful CRO by Surrounding Yourself with the Right Team Members

  • Published on: August 28, 2015

It is very important for executives of CRO companies to recognize that the most critical factor in making a CRO successful is the people that…

Read More

Starting a CRO on Personal Credit

  • Published on: July 1, 2015

Bioanalysis Zone Regardless of the size of the CRO, the quality of the work that I received was most dependent on the specific team managing…

Read More

Evaluating the Immunogenicity of Antibody–drug Conjugates

  • Published on: May 8, 2015

Antibody–drug conjugates (ADCs) represent an innovative therapeutic approach that provides novel treatment options and hope for patients with cancer and infectious disease. In fact, ADCs…

Read More

Development and validation of an alpha fetoprotein immunoassay

  • Published on: November 6, 2013

Abstract Circulating alpha fetoprotein (AFP) is a diagnostic and prognostic biomarker for hepatocellular carcinoma (HCC) with potential utility as a pharmacodynamic endpoint in rodent tumor…

Read More

Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis

  • Published on: November 5, 2013

Abstract Pharmacokinetic properties of biotherapeutics are an important aspect of preclinical drug development. The lead identification and optimization space is characterized by aggressive timelines, large…

Read More